glp 1 liver toxicity Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? glp 1 agonist liver disease

Although several limitations exist in the analysis of the FAERS database, the preliminary findings in this work could provide a better basis for understanding the potential psychiatric AEs that may occur with GLP-1 RA treatment, assisting clinicians to focus on these AEs and provide early intervene for optimal risk management

Their widespread presence throughout the body, particularly in high concentrations in the liver, kidneys, lungs, and intestines, underscores their critical role in protecting cells and tissues from a constant influx of endogenous and exogenous toxins

doi: 10.3389/fimmu.2022.912933 209 ZhangDJingBChenZNLiXShiHMZhengYCet al

We deliver medications between Monday and Saturday

That said, many providers report that patients who follow the sublingual protocol precisely, correct technique, consistent daily dosing, proper escalation, do achieve clinically meaningful results